<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OALibJ</journal-id><journal-title-group><journal-title>Open Access Library Journal</journal-title></journal-title-group><issn pub-type="epub">2333-9705</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/oalib.1105876</article-id><article-id pub-id-type="publisher-id">OALibJ-96395</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biomedical&amp;Life Sciences</subject><subject> Business&amp;Economics</subject><subject> Chemistry&amp;Materials Science</subject><subject> Computer Science&amp;Communications</subject><subject> Earth&amp;Environmental Sciences</subject><subject> Engineering</subject><subject> Medicine&amp;Healthcare</subject><subject> Physics&amp;Mathematics</subject><subject> Social Sciences&amp;Humanities</subject></subj-group></article-categories><title-group><article-title>
 
 
  Clinical Profile and Etiologies of Heart Failure at the Regional University Hospital Centre of Ouahigouya
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Joël</surname><given-names>Bamouni</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Salam</surname><given-names>Ouédraogo</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Edgar</surname><given-names>W. Ouédraogo</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Nongoba</surname><given-names>Sawadogo</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Dangwé</surname><given-names>Temoua Naibe</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Dakaboué</surname><given-names>Germain Mandi</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Hervé</surname><given-names>W. P. Kaboré</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Patrice</surname><given-names>Zabsonré</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib></contrib-group><aff id="aff4"><addr-line>Cardiology Department, Yalgado Ouédraogo University Hospital, Ouagadougou, Burkina Faso</addr-line></aff><aff id="aff3"><addr-line>National General Reference Hospital of N’Djamena, N'Djaména, Chad</addr-line></aff><aff id="aff5"><addr-line>Health Sciences Training and Research Unit, Ouaga I University: Professor Joseph Ki-Zerbo, Ouagadougou, Burkina Faso</addr-line></aff><aff id="aff2"><addr-line>Higher School of Health Sciences, University of Ouahigouya, Ouahigouya, Burkina Faso</addr-line></aff><aff id="aff1"><addr-line>Department of Medicine, Ouahigouya Regional University Hospital, Ouahigouya, Burkina Faso</addr-line></aff><pub-date pub-type="epub"><day>05</day><month>11</month><year>2019</year></pub-date><volume>06</volume><issue>11</issue><fpage>1</fpage><lpage>7</lpage><history><date date-type="received"><day>23,</day>	<month>October</month>	<year>2019</year></date><date date-type="rev-recd"><day>12,</day>	<month>November</month>	<year>2019</year>	</date><date date-type="accepted"><day>15,</day>	<month>November</month>	<year>2019</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Introduction: Heart failure is a public health concern nowadays. It is the possible outcome of any cardiovascular pathology during its evolution. It is therefore one of the main causes of hospitalization but also of the death of these patients. Objective: The objective of our study was to describe the clinical profile and etiologies of acute heart failure at the Regional University Hospital Centre of Ouahigouya. Methods and Patients: This was a ret-rospective study over a twelve (12) months period from January 1 to De-cember 31, 2017 in the medical department of the Regional University Hospital Centre of Ouahigouya. The patients admitted for heart failure during the period were our study population. Results: During our study period, we collected 123 cases of hospitalizations for heart failure, representing 8.33% of hospitalizations in the medical department. The average age of the patients was 52.7 &#177; 21 years with a sex ratio of 0.80. Dyspnea was the most observed functional sign (97.56%) and heart failure was global in 88.62% of cases. Hypertensive heart disease was the most common etiology with 37.40%. The average length of hospitalization was 10.18 &#177; 2.64 days. Conclusion: Our study showed that high blood pressure remains the main risk factor for heart failure in our context. This heart failure is willingly global and the average hospital stay remains relatively long.
 
</p></abstract><kwd-group><kwd>Heart Failure</kwd><kwd> Clinical Profile</kwd><kwd> Etiologies</kwd><kwd> Regional University Hospital  Center of Ouahigouya</kwd><kwd> Burkina Faso</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Heart failure is nowadays a major public health problem, the ultimate outcome of most cardiovascular diseases and one of the most frequent causes of hospitalization [<xref ref-type="bibr" rid="scirp.96395-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.96395-ref2">2</xref>] . His positive diagnosis is clinical (functional signs and clinical examination of diseases) [<xref ref-type="bibr" rid="scirp.96395-ref3">3</xref>] , but suffers from a delay in our work context. Its treatment is now well codified and allows a reduction in morbidity and mortality so well conducted.</p><p>Because of the epidemiological transition, cardiovascular diseases are becoming more and more prevalent in developing countries, including ours. The prevalence of heart failure is increasing with aging and improved treatment in developed [<xref ref-type="bibr" rid="scirp.96395-ref4">4</xref>] . In our context, the increase in prevalence is mainly marked by delays in consultation and the chaotic care pathway of patients before the onset of heart failure [<xref ref-type="bibr" rid="scirp.96395-ref5">5</xref>] . This means that heart failure will increasingly become a daily occurrence in the health services of these countries.</p><p>Our hospital is located in the capital of one of the poorest regions in Burkina Faso (low purchasing power of the population). In addition, the University Hospital is very young (two years old). The objective of this first study on heart failure is to describe the clinical and etiological profile of this pathology in our practice in a semi-rural environment in Burkina Faso.</p></sec><sec id="s2"><title>2. Patients and Methods</title><p>This was a descriptive retrospective study over a twelve (12) month period from January 1 to December 31, 2017. It took place in the medical department of the Ouahigouya Regional University Hospital.</p><p>Our sampling population included all patients hospitalized in medicine during the study period and the study population included patients admitted for heart failure.</p><p>Included in our study were patients with heart failure over 15 years of age who were hospitalized during the study period and whose clinical records were usable. All patients whose clinical records were not usable were excluded from the study.</p><p>Data collection was concerned about the socio-demographics, clinical, electrocardiogram, echocardiography and outcomes aspect during the period of hospitalization. The data were analyzed using Epi-info 3.5.3 and Rsoftware. Data confidentiality and patient anonymity were respected before the data were processed for ethical considerations.</p></sec><sec id="s3"><title>3. Results</title><p>During our study period, we collected 123 cases of hospitalizations for heart failure for 1476 hospitalizations, representing 8.3% of hospitalizations in the medical department.</p><sec id="s3_1"><title>3.1. Socio-Demographic Characteristics</title><p>The average age of the patients was 52.7 &#177; 21 years with extremes of 18 and 93 years. The male sex represented 44.7% (n = 55) of patients or a sex ratio of 0.80. Housewives and farmers accounted for 92.7% (n = 114) of cases. Patients resided in urban areas in 29.3% (n = 36) of cases. <xref ref-type="table" rid="table1">Table 1</xref> shows the distribution of patients by socio-demographics characteristics.</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Socio-demographic and clinical characteristics of patients at admission</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Parameters</th><th align="center" valign="middle" >Value (%)</th></tr></thead><tr><td align="center" valign="middle" >Age range (years)</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >≤45</td><td align="center" valign="middle" >51 (41.4)</td></tr><tr><td align="center" valign="middle" >46 - 55</td><td align="center" valign="middle" >10 (8.1)</td></tr><tr><td align="center" valign="middle" >56 - 65</td><td align="center" valign="middle" >19 (15.5)</td></tr><tr><td align="center" valign="middle" >&gt;65</td><td align="center" valign="middle" >43 (35)</td></tr><tr><td align="center" valign="middle" >Sex</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >55 (44.7)</td></tr><tr><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >68 (55.3)</td></tr><tr><td align="center" valign="middle" >Profession, n (%)</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Housewife</td><td align="center" valign="middle" >66 (53.7)</td></tr><tr><td align="center" valign="middle" >Cultivator</td><td align="center" valign="middle" >48 (39)</td></tr><tr><td align="center" valign="middle" >Breeder</td><td align="center" valign="middle" >2 (1.6)</td></tr><tr><td align="center" valign="middle" >Retired</td><td align="center" valign="middle" >2 (1.6)</td></tr><tr><td align="center" valign="middle" >Student</td><td align="center" valign="middle" >2 (1.6)</td></tr><tr><td align="center" valign="middle" >Employee</td><td align="center" valign="middle" >3 (2.4)</td></tr><tr><td align="center" valign="middle" >Cardiovascular risk factors, n (%)</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Hypertension</td><td align="center" valign="middle" >46 (37.4)</td></tr><tr><td align="center" valign="middle" >Diabetes</td><td align="center" valign="middle" >8 (6.50)</td></tr><tr><td align="center" valign="middle" >Dyslipidemia</td><td align="center" valign="middle" >7 (5.69)</td></tr><tr><td align="center" valign="middle" >Smoking</td><td align="center" valign="middle" >9 (7.32)</td></tr><tr><td align="center" valign="middle" >Alcohol abuse, n (%)</td><td align="center" valign="middle" >6 (4.9)</td></tr><tr><td align="center" valign="middle" >Functional and clinical signs at admission</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >NYHA Stage III-IV de la, n (%)</td><td align="center" valign="middle" >120 (97.6)</td></tr><tr><td align="center" valign="middle" >Cough, n (%)</td><td align="center" valign="middle" >45 (36.6)</td></tr><tr><td align="center" valign="middle" >Precordialgia, n (%)</td><td align="center" valign="middle" >71 (57.7)</td></tr><tr><td align="center" valign="middle" >Palpitations, n (%)</td><td align="center" valign="middle" >17 (13.8)</td></tr><tr><td align="center" valign="middle" >dizziness, n (%)</td><td align="center" valign="middle" >2 (1.6)</td></tr><tr><td align="center" valign="middle" >Lower limbs oedemas n (%)</td><td align="center" valign="middle" >64 (52)</td></tr><tr><td align="center" valign="middle" >Left heart failure syndrome, n (%)</td><td align="center" valign="middle" >6 (4.9)</td></tr><tr><td align="center" valign="middle" >Right heart failure syndrome, n (%)</td><td align="center" valign="middle" >6 (4.9)</td></tr><tr><td align="center" valign="middle" >Congestive heart failure syndrome, n (%)</td><td align="center" valign="middle" >109 (88.6)</td></tr></tbody></table></table-wrap><p>NYHA: New York Heart Association.</p></sec><sec id="s3_2"><title>3.2. Clinical Characteristics at Admission</title><p>We noted a history of hospitalization for heart failure in one case. High blood pressure was the cardiovascular risk factor in 37.4% (n = 46) of cases. <xref ref-type="table" rid="table1">Table 1</xref> shows the distribution of cardiovascular risk factors.</p></sec><sec id="s3_3"><title>3.3. Functional and Clinical Signs at Admission</title><p>Ninety-seven decimal six percent (n = 120) of patients had dyspnea. This dyspnea was assessed at a stage III or IV of the New York Heart Association (NYHA). Pre-cordialgia was noted in 57.7% (n = 71) of patients. Patients had congestive heart failure in 88.9% (n = 109) of cases. <xref ref-type="table" rid="table1">Table 1</xref> presents the distribution of patients by functional and clinical signs at admission.</p></sec><sec id="s3_4"><title>3.4. Paraclinical Characteristics of Patients</title><p>On electrocardiogram, complete arrhythmia by atrial fibrillation was noted in 13.1% (n = 16) of cases and left ventricular hypertrophy in 75.6% (n = 93) of cases. Severe alteration of left ventricular ejection fraction was noted in 78.1% (n = 96). The average creatinine clearance was 152.9 &#181;mol/l. <xref ref-type="table" rid="table2">Table 2</xref> shows the distribution of patients by paraclinical characteristics.</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Paraclinical characteristics</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Characteritics</th><th align="center" valign="middle" >Value (%)</th></tr></thead><tr><td align="center" valign="middle" >Electrocardiographic parameters</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Heart ratemean &#177; SD, cycles/minute</td><td align="center" valign="middle" >114.4 &#177; 15.1</td></tr><tr><td align="center" valign="middle" >Atrial fibrillation n (%)</td><td align="center" valign="middle" >16 (13.1)</td></tr><tr><td align="center" valign="middle" >Ventricular extrasystoles n (%)</td><td align="center" valign="middle" >15 (12.4)</td></tr><tr><td align="center" valign="middle" >Left ventricular hypertrophy n (%)</td><td align="center" valign="middle" >93 (75.6)</td></tr><tr><td align="center" valign="middle" >Left atrial hypertrophy n (%)</td><td align="center" valign="middle" >58 (47.2)</td></tr><tr><td align="center" valign="middle" >Myocardial ischemia n (%)</td><td align="center" valign="middle" >17 (14.3)</td></tr><tr><td align="center" valign="middle" >Complete left branch block n (%)</td><td align="center" valign="middle" >2 (1.6)</td></tr><tr><td align="center" valign="middle" >Complete right branch block n (%)</td><td align="center" valign="middle" >2 (1.6)</td></tr><tr><td align="center" valign="middle" >Cardiac echographicparameters</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Left ventricular ejection fraction &lt; 40%, n (%)</td><td align="center" valign="middle" >96 (78.1)</td></tr><tr><td align="center" valign="middle" >Left ventricular ejection fraction between 40% - 50%, n (%)</td><td align="center" valign="middle" >17 (13.8)</td></tr><tr><td align="center" valign="middle" >Left ventricular ejection fraction ≥ 50%, n (%)</td><td align="center" valign="middle" >10 (8.1)</td></tr><tr><td align="center" valign="middle" >Biological parameters</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Fasting blood glucose, mean &#177; SD, mmol/l</td><td align="center" valign="middle" >5.3 &#177; 1.8</td></tr><tr><td align="center" valign="middle" >Creatininemia, mean &#177; SD, &#181;mol/l</td><td align="center" valign="middle" >152.9 &#177; 270.8</td></tr><tr><td align="center" valign="middle" >Creatinine clearance, mean &#177; SD, ml/min/1.73 m<sup>2</sup></td><td align="center" valign="middle" >71.6 &#177; 31.9</td></tr><tr><td align="center" valign="middle" >Severe renal failure (GFR &lt; 30 ml/min/1.73 m<sup>2</sup>)</td><td align="center" valign="middle" >9 (7.32)</td></tr><tr><td align="center" valign="middle" >hemoglobin level mean &#177; SD, g/dl</td><td align="center" valign="middle" >11.4 &#177; 2.4</td></tr></tbody></table></table-wrap><p>SD = standard deviation; GFR = glomerular filtration flow rate.</p></sec><sec id="s3_5"><title>3.5. Etiologies of Heart Failure</title><p>Heart failure was due in 37.4% (n = 46) of patients to hypertensive heart disease and valvulopathy in 14.6% (n = 16) of patients. Peripartum cardiomyopathy accounted for 13% (n = 16) of heart failure cases and 19% of causes of heart failure in women. The distribution of patients by etiology is presented in <xref ref-type="table" rid="table3">Table 3</xref>.</p></sec><sec id="s3_6"><title>3.6. Evolution</title><p>The average length of hospitalization was 10.2 &#177; 2.6 days with extremes of 4 and 15 days.</p><p>Treatment of patients was based on loop diuretics in 98.4% (n = 121), enzyme conversion inhibitors or angiotensin receptor antagonists in 93.5% (n = 115) and anti-aldosterone in 85.4% (n = 105) of cases. Beta-adrenergic blocking agents were used in 12.2% (n = 15) of patients. <xref ref-type="table" rid="table4">Table 4</xref> shows distribution of patient according to receiving treatment.</p><p>Intra-hospital evolution is marked by death in 17.9% (n = 22) of cases.</p></sec></sec><sec id="s4"><title>4. Discussion</title><p>The hospital prevalence of heart failure was 8.3% in our study, all medical causes combined. This prevalence is important if we take into account the share of heart failure in total cardiovascular disease. It is the terminal phase of the progression of most heart diseases; and this prevalence in our context could be explained by a delay in consultation―as evidenced by the main reason for consultation, which is NYHA Stage III-IV dyspnea―and a chaotic care path for patients. Indeed, Yameogo, in his study on the care pathways of patients with heart failure in Burkina Faso, showed that all actors (health workers, patients and the health system) each have a responsibility in the poor quality of patient care [<xref ref-type="bibr" rid="scirp.96395-ref5">5</xref>] . These delays could explain the significant alteration of the left ventricular ejection function (LVEF &lt; 40%) and the high mortality rate at 17%. Yam&#233;ogo and Kologo in studies on the causes of cardiovascular mortality in</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Etiologies of heart failure</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Etiologies</th><th align="center" valign="middle" >Frequency</th><th align="center" valign="middle" >Percentage</th></tr></thead><tr><td align="center" valign="middle" >Hypertensive heart disease</td><td align="center" valign="middle" >46</td><td align="center" valign="middle" >37.4</td></tr><tr><td align="center" valign="middle" >Ischemic heart disease</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >6.5</td></tr><tr><td align="center" valign="middle" >Idiopathic heart disease</td><td align="center" valign="middle" >23</td><td align="center" valign="middle" >18.7</td></tr><tr><td align="center" valign="middle" >Peri partum cardiomyopathy</td><td align="center" valign="middle" >16</td><td align="center" valign="middle" >13</td></tr><tr><td align="center" valign="middle" >Valvulopathy</td><td align="center" valign="middle" >18</td><td align="center" valign="middle" >14.6</td></tr><tr><td align="center" valign="middle" >Myopericarditis</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.81</td></tr><tr><td align="center" valign="middle" >Hypertrophic cardiomyopathy</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.81</td></tr><tr><td align="center" valign="middle" >Anemic heart</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >2.43</td></tr><tr><td align="center" valign="middle" >Chronic pulmonary heart</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >5.69</td></tr></tbody></table></table-wrap><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Treatments received during hospitalization</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Characteristic</th><th align="center" valign="middle" >Frequency</th><th align="center" valign="middle" >Percentage</th></tr></thead><tr><td align="center" valign="middle" >Loop diuretics</td><td align="center" valign="middle" >121</td><td align="center" valign="middle" >98.4</td></tr><tr><td align="center" valign="middle" >Nitrogen derivatives</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >5.7</td></tr><tr><td align="center" valign="middle" >Enzyme conversion inhibitors/Angiotensin receptor antagonists</td><td align="center" valign="middle" >115</td><td align="center" valign="middle" >93.5</td></tr><tr><td align="center" valign="middle" >Beta adrenergic blocking agents</td><td align="center" valign="middle" >15</td><td align="center" valign="middle" >12.2</td></tr><tr><td align="center" valign="middle" >Antialdosterones</td><td align="center" valign="middle" >105</td><td align="center" valign="middle" >85.4</td></tr><tr><td align="center" valign="middle" >Calcium antagonists</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >1.6</td></tr><tr><td align="center" valign="middle" >Anti platelets agents</td><td align="center" valign="middle" >45</td><td align="center" valign="middle" >36.6</td></tr><tr><td align="center" valign="middle" >Amiodarone</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >3.2</td></tr><tr><td align="center" valign="middle" >Digoxin</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >2.4</td></tr><tr><td align="center" valign="middle" >Enoxaparin</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >1.6</td></tr><tr><td align="center" valign="middle" >Antivitamin K</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >1.6</td></tr><tr><td align="center" valign="middle" >Statins</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >3.2</td></tr><tr><td align="center" valign="middle" >Insulin</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >1.6</td></tr><tr><td align="center" valign="middle" >Metformin</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >4.06</td></tr><tr><td align="center" valign="middle" >Blood transfusion</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >4.06</td></tr><tr><td align="center" valign="middle" >Iron</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >3.25</td></tr></tbody></table></table-wrap><p>Ouagadougou and Koudougou respectively noted that cardiac IC was the leading immediate cause of death in our context [<xref ref-type="bibr" rid="scirp.96395-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.96395-ref7">7</xref>] .</p><p>Hypertensive heart disease was the main etiology of heart failure in our study. This observation was made by Yameogo and Kologo in their study [<xref ref-type="bibr" rid="scirp.96395-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.96395-ref7">7</xref>] . This is due to delayed diagnosis of high blood pressure, poor compliance with treatment and patients’ inability to provide regular treatment for high blood pressure [<xref ref-type="bibr" rid="scirp.96395-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.96395-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.96395-ref9">9</xref>] . A policy to prevent cardiovascular disease and the introduction of health insurance within society could improve not only primary and secondary prevention.</p><p>Our study was conducted in the medical department of the Ouahigouya Regional University Hospital. Ouahigouya is a medium-sized city in Burkina Faso, it is the capital of the northern region, which is one of the poorest in the country. This makes our patients among the poorest and makes it difficult for them to cope with health-related expenses, especially when it comes to chronic diseases such as heart failure. This situation partly explains the fact that the paraclinical check-up could not be done in all patients, particularly the etiological check-up, thus limiting our study, which was at their expense. This hospital has a limited technical platform in the exploration of this complex pathology and constitutes the crossroads of most pathologies in cardiology. Despite these limitations in our work, the results allow us to make an inventory and have a global vision of this pathology in our region.</p></sec><sec id="s5"><title>5. Conclusion</title><p>Heart failure remains a frequent cause of admission of cardiac patients to the hospital. The main etiology, high blood pressure, can be prevented by primary prevention in the population and better medical care. Our study made it possible to make an inventory of this pathology which is serious with a poor prognosis. A better approach to the diagnosis and management of the causes of heart failure before hospitalization is needed and an improved technical platform is very important for reducing mortality in hospitals.</p></sec><sec id="s6"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s7"><title>Cite this paper</title><p>Bamouni, J., Ou&#233;draogo, S., Ou&#233;draogo, E.W., Sawadogo, N., Naibe, D.T., Mandi, D.G., Kabor&#233;, H.W.P. and Zabsonr&#233;, P. (2019) Clinical Profile and Etiologies of Heart Failure at the Regional University Hospital Centre of Ouahigouya. Open Access Library Journal, 6: e5876. https://doi.org/10.4236/oalib.1105876</p></sec></body><back><ref-list><title>References</title><ref id="scirp.96395-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Miller, L.W. and Missov, E.D. (2001) Epidemiology of Heart Failure. Cardiology Clinics, 19, 547?555. https://doi.org/10.1016/S0733-8651(05)70242-3 </mixed-citation></ref><ref id="scirp.96395-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Roger, V.L. (2013) Epidemiology of Heart Failure. Circulation Research, 113, 646-659. https://doi.org/10.1161/CIRCRESAHA.113.300268</mixed-citation></ref><ref id="scirp.96395-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Mosterd, A. and Hoes, A.W. (2007) Clinical Epidemiology of Heart Failure. Heart, 93, 1137-1146. https://doi.org/10.1136/hrt.2003.025270</mixed-citation></ref><ref id="scirp.96395-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Savarese, G. and Lund, L.H. (2017) Global Public Health Burden of Heart Failure. Cardiac Failure Review, 3, 7-11.</mixed-citation></ref><ref id="scirp.96395-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Yaméogo, R.A., Nikiéma, J.W.-Z., Bamouni, J., Naibe, D.T., Mandi, D.G., Kambire, Y., et al. (2018) Parcours de soins du patient insuffisant cardiaque au Burkina Faso. Revue Tunisienne de Cardiologie, 14, 175-183.</mixed-citation></ref><ref id="scirp.96395-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Yameogo, A.R., Mandi, G., Millogo, G., Samadoulougou, A. and Zabsonre, P. (2014) Assessing Causes of Death in the Cardiology Department of Yalgado Ouédraogo University Hospital. The Pan African Medical Journal, 19, 155. https://doi.org/10.11604/pamj.2014.19.155.5286</mixed-citation></ref><ref id="scirp.96395-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Kologo, K.J., Yaméogo, R.A., Bamouni, J., Balima, S., Millogo, G.R.C. and Zabsonré, P. (2016) Cardiovascular Death in the Regional Hospital of Koudougou. Open Access Library Journal, 3, 1-9. https://doi.org/10.4236/oalib.1103201</mixed-citation></ref><ref id="scirp.96395-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Samadoulougou, A., Lengani, A., Yameogo, R., Millogo, G., Kologo, K., Toguyeni, B., et al. (2009) Hypertension artérielle maligne: Aspects épidémiologiques, cliniques et évolutifs dans le service de cardiologie du CHU Yalgado OUEDRAOGO. Annales de l’Université de Ouagadougou, 7, 1-22.</mixed-citation></ref><ref id="scirp.96395-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Yameogo, R.A., Mandi, D.G., Yameogo, N.V., Millogo, G.R.C., Kologo, K.J., Toguyeni, B.J.Y., et al. (2014) La super hypertension artérielle en milieu cardiologique au Burkina Faso. Annales de Cardiologie et d’Angéiologie, 63, 151-154. https://doi.org/10.1016/j.ancard.2014.04.010</mixed-citation></ref></ref-list></back></article>